Krzysztof Wierbilowicz
@wierbilowicz.bsky.social
PhD Student @ Karolinska Institutet | Drug combination therepies for neuroblastoma and cellular barcoding
Thanks a lot for sharing the preprint!
Now available in The EMBO Journal: www.embopress.org/doi/full/10....
Now available in The EMBO Journal: www.embopress.org/doi/full/10....
July 23, 2025 at 8:54 AM
Thanks a lot for sharing the preprint!
Now available in The EMBO Journal: www.embopress.org/doi/full/10....
Now available in The EMBO Journal: www.embopress.org/doi/full/10....
Our new work in @embojournal.org ! 🎉
PARP7 creates an ADP-ribosyl degron on chromatin-bound AR, leading to DTX2-mediated degradation and negative feedback in androgen signaling in prostate cancer.
Full: www.embopress.org/doi/full/10....
#ProstateCancer #PARP7 #AndrogenReceptor #TheEMBOJournal
PARP7 creates an ADP-ribosyl degron on chromatin-bound AR, leading to DTX2-mediated degradation and negative feedback in androgen signaling in prostate cancer.
Full: www.embopress.org/doi/full/10....
#ProstateCancer #PARP7 #AndrogenReceptor #TheEMBOJournal
July 23, 2025 at 8:52 AM
Our new work in @embojournal.org ! 🎉
PARP7 creates an ADP-ribosyl degron on chromatin-bound AR, leading to DTX2-mediated degradation and negative feedback in androgen signaling in prostate cancer.
Full: www.embopress.org/doi/full/10....
#ProstateCancer #PARP7 #AndrogenReceptor #TheEMBOJournal
PARP7 creates an ADP-ribosyl degron on chromatin-bound AR, leading to DTX2-mediated degradation and negative feedback in androgen signaling in prostate cancer.
Full: www.embopress.org/doi/full/10....
#ProstateCancer #PARP7 #AndrogenReceptor #TheEMBOJournal